May 21, 2024
Teva and Alvotech launch SIMLANDI in US for arthritis
Teva and Alvotech have announced the US launch of SIMLANDI (adalimumab-ryvk) injection, as an interchangeable biosimilar to the reference product Humira to treat arthritis.